iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) Stock Price Down 2.6% – Here’s What Happened

iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE)’s stock price dropped 2.6% during trading on Thursday . The stock traded as low as $28.68 and last traded at $28.99. Approximately 12,857 shares changed hands during trading, an increase of 125% from the average daily volume of 5,713 shares. The stock had previously closed at $29.75.

iShares LifePath Target Date 2045 ETF Price Performance

The firm has a market cap of $23.19 million, a price-to-earnings ratio of 19.46 and a beta of 0.90. The business has a fifty day simple moving average of $31.08 and a 200 day simple moving average of $31.49.

Institutional Trading of iShares LifePath Target Date 2045 ETF

A hedge fund recently bought a new stake in iShares LifePath Target Date 2045 ETF stock. Heck Capital Advisors LLC purchased a new position in shares of iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 869 shares of the company’s stock, valued at approximately $27,000. Heck Capital Advisors LLC owned about 0.27% of iShares LifePath Target Date 2045 ETF at the end of the most recent quarter.

About iShares LifePath Target Date 2045 ETF

The iShares LifePath Target Date 2045 ETF USD (ITDE) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches.